Skip to content
Recall Observatory FDA recall evidence

Drug product

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25 vials/shelf-pack (NDC 0641-6042-25), For IV or IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

D-0864-2020

December 17, 2019

Class I

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 84534
Status
Terminated
Classification
Class I
Quantity
101,710 25 vials/shelf-pack
Official record key
drug-enforcement:D-0864-2020

Official wording

Reason: Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Code information: Lot #: 038366, Exp. Date Mar 2020; 048365, 048367, Exp. Date Apr 2020; 078301, 078303, Exp. Date July 2020; 118358, Exp. Date Nov 2020; 029353, Exp. Date Feb 2021; 019413, Exp. Date Jan 2021

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter